Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 81
Optical 75
Immune Disorders Drugs 73
Optical Disorders Drugs 68
Drug Discovery 54
Cardiovascular Drugs 46
Biopharmaceuticals 37
Dermatological Drugs 37
Musculoskeletal Disorders Drugs 37
Biotechnology 33
Genomics 28
Clinical Trials 22
Central Nervous System Drugs 19
Pharmaceuticals 19
Skin Cancer Drugs 19
Endocrine and Metabolic Disorders Drugs 19
Infectious Diseases Drugs 18
Allergy and Immunology 17
Drugs by Therapeutic Area 16
Respiratory Drugs 15
Infusions and Injectables 14
Allergy Drugs 13
Lung Cancer Drugs 12
Gastrointestinal Drugs 11
Dermatology 10
Oncology 10
Hematological Drugs 9
Leukemia Drugs 8
Needles and Syringes 8
Diagnostics 7
Biosimilars and Biosuperiors 7
Pharmaceutical Manufacturing 7
Prostate Cancer Drugs 6
Enzymes 6
Vaccines 6
Asthma Drugs 6
Therapeutic Area 5
Drug Delivery 5
Liver and Kidney Disorders Drugs 5
Gastroenterology 5
Company Reports 4
Pulmonary Medicine 4
Lymphoma Drugs 4
Ovarian Cancer Drugs 4
Proteomics 4
Transdermal and Transmucosal Drug Delivery 4
Pharmaceutical Intermediates 3
Diabetes Drugs 3
Colon Cancer Drugs 3
Cardiovascular Devices 3
Medical Devices 3
Pediatrics 3
Endocrinology 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Healthcare Services 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Analgesics 2
Cough and Cold Drugs 2
Mental Disorders Drugs 2
Kidney Cancer Drugs 2
Thyroid Cancer Drugs 2
Laboratory Equipment 2
Anti-Obesity Drugs 2
Cardiology 2
Neurology 1
Hepatology 1
Generic Drugs 1
Pharmacoeconomics 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Cholesterol Testing 1
Laboratory Testing 1
Inhalers and Nebulisers 1
Stem Cells 1
Blood Banking 1
Anesthetic Drugs 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Pancreatic Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

682 Results (Page 18 of 35)
- Relevance
  Sort by

$Refractory Multiple Myeloma- Pipeline Insight, 2025 - Product Thumbnail Image$

Refractory Multiple Myeloma- Pipeline Insight, 2025

 Clinical Trials
April 2025
180 Pages
Global

From

€2669EUR$3,000USD£2,318GBP

Ebola Drugs and Vaccines - Global Strategic Business Report

 Report
October 2025
485 Pages
Global

From

€5204EUR$5,850USD£4,521GBP

Waldenstrom Macroglobulinemia - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€7072EUR$7,950USD£6,144GBP

Multiple Myeloma - Market Insight, Epidemiology, and Market Forecast - 2034

 Report
April 2025
200 Pages
Global

From

€7072EUR$7,950USD£6,144GBP

Peritoneal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
June 2022
925 Pages
Global

From

€2224EUR$2,500USD£1,932GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Follicular Lymphoma - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€7072EUR$7,950USD£6,144GBP

Glucagon-like Peptide 1 Global Market Report 2025

 Report
July 2025
250 Pages
Global

From

€3994EUR$4,490USD£3,470GBP

Retinal Drugs Market 2025-2029

 Report
April 2025
217 Pages
Global

From

€2224EUR$2,500USD£1,932GBP

Post-Traumatic Stress Disorder Therapeutics Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3994EUR$4,490USD£3,470GBP

Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market Industry Trends and Global Forecasts to 2035, by Scale of Operation, Type of Vector, Application Area, Therapeutic Area, Type of Manufacturer and Geographical Region

 Report
January 2025
768 Pages
Global

From

€4269EUR$4,799USD£3,709GBP

Peanut Allergy - Pipeline Insight, 2025

 Clinical Trials
July 2025
60 Pages
Global

From

€1334EUR$1,500USD£1,159GBP

CAR-T Funding Report - Venture Capital, IPOs, Licensing Deals, Collaborations, and M&A Transactions, 2025

 Report
April 2025
220 Pages
Global

From

€1776EUR$1,997USD£1,543GBP

Connective Tissue Diseases - Global Strategic Business Report

 Report
October 2025
385 Pages
Global

From

€5204EUR$5,850USD£4,521GBP

Human Gene Sequencing Markets, Strategies & Trends: Forecasts By Application, By Technology, By Workflow, By Product, and By Country with Executive and Consultant Guides

 Report
October 2025
835 Pages
Global

From

€6222EUR$6,995USD£5,406GBP

Whole Genome and Exome Sequencing Market: By Application, Organism and Product with Executive and Consultant Guides

 Report
October 2025
681 Pages
Global

From

€6222EUR$6,995USD£5,406GBP

Antibody Drug Conjugate Market Industry Trends and Global Forecasts to 2035, by Target Disease Indication, Therapeutic Area, Linker, Payload, Target Antigens and Key Geographical Regions

 Report
November 2024
716 Pages
Global

From

€4269EUR$4,799USD£3,709GBP

Skeletal Dysplasia - Global Strategic Business Report

 Report
October 2025
378 Pages
Global

From

€5204EUR$5,850USD£4,521GBP

Non-small Cell Lung Cancer Drugs Market 2023-2027

 Report
May 2023
167 Pages
Global

From

€2224EUR$2,500USD£1,932GBP

Postpartum Depression Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3994EUR$4,490USD£3,470GBP

Cancer Immunotherapy Market 2025-2029 - Forecasts for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer, with Executive and Consultant Guides

 Report
October 2025
262 Pages
Global

From

€6222EUR$6,995USD£5,406GBP

682 Results (Page 18 of 35)
- 1
- 16
- 17
- 18
- 19
- 20

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.